0000950142-17-000550.txt : 20170309
0000950142-17-000550.hdr.sgml : 20170309
20170309132155
ACCESSION NUMBER: 0000950142-17-000550
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170307
FILED AS OF DATE: 20170309
DATE AS OF CHANGE: 20170309
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEMPRA, INC.
CENTRAL INDEX KEY: 0001461993
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262644445
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6320 QUADRANGLE DRIVE
STREET 2: SUITE 360
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517-8149
BUSINESS PHONE: 919-576-2306
MAIL ADDRESS:
STREET 1: 6320 QUADRANGLE DRIVE
STREET 2: SUITE 360
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517-8149
FORMER COMPANY:
FORMER CONFORMED NAME: Cempra Holdings, LLC
DATE OF NAME CHANGE: 20090414
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN DOV A MD
CENTRAL INDEX KEY: 0001120478
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35405
FILM NUMBER: 17677721
4
1
es1700390_4-goldstein.xml
OWNERSHIP DOCUMENT
X0306
4
2017-03-07
0
0001461993
CEMPRA, INC.
CEMP
0001120478
GOLDSTEIN DOV A MD
888 7TH AVENUE
12TH FLOOR
NEW YORK
NY
10106
1
0
0
0
Common Stock
2017-03-07
4
S
0
50100
3.5264
D
99900
I
By Aisling Capital II, LP
Common Stock
2017-03-08
4
S
0
99900
3.5680
D
0
I
By Aisling Capital II, LP
Common Stock
95
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.500 to $3.575, inclusive. The reporting person undertakes to provide to Cempra, Inc., any security holder of Cempra, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.500 to $3.575, inclusive. The reporting person undertakes to provide to Cempra, Inc., any security holder of Cempra, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The reportable securities are owned directly by Aisling Capital II, LP ("Aisling"), and held indirectly by Aisling GP, as general partner of Aisling, and Aisling Capital Partners, LLC, as general partner of Aisling GP. Dr. Goldstein is a member of the investment committee of Aisling. Dr. Goldstein disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
/s/ Dov Goldstein
2017-03-09